Insider trading

Period: 120 months Stock: KYNB Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

75 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

75 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

75 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

75 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
75 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
75 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

75 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
12 Jun 2024
Adib Deyaa Chief Medical Officer
Bought
$25.88K 22,123 at 1.17
36.9%
First buy on file
23 Jun 2023
Wettig Thane Chief Commercial Officer
Sold at will
$13.07K 791 at 16.53
0.7%
Not planned
14 Jun 2023
Chung Christine SVP, China Operations
Sold on a plan 2×
$104.93K 6,250 at 16.79
2.6%
Planned (10b5-1)
13 Jun 2023
Chung Christine SVP, China Operations
Sold on a plan
$110.00K 6,250 at 17.60
2.5%
Planned (10b5-1)
7 Jun 2023
Chung Christine SVP, China Operations
Sold at will 3×
$61.89K 3,633 at 17.04
1.4%
Not planned
7 Jun 2023
Eisner Mark EVP, Chief Medical Officer
Sold at will
$34.79K 2,042 at 17.04
1.2%
Not planned
7 Jun 2023
Wettig Thane Chief Commercial Officer
Sold at will 2×
$29.95K 1,758 at 17.04
1.6%
Not planned
2 Jun 2023
Eisner Mark EVP, Chief Medical Officer
Sold at will
$20.52K 1,090 at 18.83
0.7%
Not planned
4 Apr 2023
Eisner Mark Chief Medical Officer
Sold at will
$172.47K 9,182 at 18.78
5.2%
Not planned
4 Apr 2023
Chung Christine SVP, China Operations
Sold at will
$123.79K 6,590 at 18.78
2.5%
Not planned
23 Mar 2023
Wettig Thane Chief Commercial Officer
Sold at will
$16.93K 905 at 18.71
0.8%
Not planned
10 Mar 2023
Eisner Mark Chief Medical Officer
Sold, plan not stated 2×
$204.80K 10,140 at 20.20
5.5%
10 Mar 2023
Wettig Thane Chief Commercial Officer
Sold, plan not stated 2×
$154.89K 7,669 at 20.20
6.4%
10 Mar 2023
Chung Christine SVP, China Operations
Sold, plan not stated 2×
$153.62K 7,606 at 20.20
2.9%
8 Mar 2023
Chung Christine SVP, China Operations
Sold, plan not stated
$176.74K 8,354 at 21.16
3.2%
8 Mar 2023
Eisner Mark Chief Medical Officer
Sold, plan not stated
$155.77K 7,363 at 21.16
4.3%
8 Mar 2023
Wettig Thane Chief Commercial Officer
Sold, plan not stated
$132.54K 6,265 at 21.16
5.7%
2 Mar 2023
Eisner Mark Chief Medical Officer
Sold, plan not stated
$25.96K 1,187 at 21.87
0.7%
23 Dec 2022
Wettig Thane Chief Commercial Officer
Sold, plan not stated
$11.60K 734 at 15.80
0.8%
8 Dec 2022
Chung Christine SVP, China Operations
Sold, plan not stated
$17.31K 1,096 at 15.79
0.5%
8 Dec 2022
Wettig Thane Chief Commercial Officer
Sold, plan not stated
$6.03K 382 at 15.79
0.4%
26 Aug 2021
Wettig Thane Chief Commercial Officer
Bought
$35.74K 3,100 at 11.53
6.8%
First buy on file
16 Dec 2020
Yu K Peony Chief Medical Officer
Sold, plan not stated
$139.39K 3,350 at 41.61
1.7%
16 Sep 2020
Yu K Peony Chief Medical Officer
Sold, plan not stated
$147.48K 3,351 at 44.01
1.7%
3 Sep 2020
Yu K Peony Chief Medical Officer
Sold, plan not stated
$508.90K 10,000 at 50.89
4.6%
24 Jul 2020
Yu K Peony Chief Medical Officer
Sold, plan not stated
$141.91K 3,351 at 42.35
1.6%
19 Mar 2020
Chung Christine SVP, China Operations
Sold, plan not stated 3×
$190.28K 7,345 at 25.91
4.4%
18 Mar 2020
Chung Christine SVP, China Operations
Sold, plan not stated 3×
$96.80K 3,905 at 24.79
2.4%
12 Feb 2020
Chung Christine SVP, China Operations
Sold, plan not stated 2×
$258.62K 5,625 at 45.98
4.1%
11 Feb 2020
Chung Christine SVP, China Operations
Sold, plan not stated
$250.20K 5,625 at 44.48
4.1%
7 Jan 2020
Chung Christine SVP, China Operations
Sold, plan not stated
$240.53K 5,625 at 42.76
4.1%
6 Jan 2020
Chung Christine SVP, China Operations
Sold, plan not stated
$241.76K 5,625 at 42.98
4.1%
17 Dec 2019
Chung Christine SVP, China Operations
Sold, plan not stated 2×
$264.24K 5,625 at 46.98
4.1%
16 Dec 2019
Chung Christine SVP, China Operations
Sold, plan not stated 2×
$264.83K 5,625 at 47.08
4.1%
16 Dec 2019
Yu K Peony Chief Medical Officer
Sold, plan not stated
$159.65K 3,420 at 46.68
1.9%
14 Nov 2019
Chung Christine SVP, China Operations
Sold, plan not stated 2×
$195.44K 5,625 at 34.74
3.9%
13 Nov 2019
Chung Christine SVP, China Operations
Sold, plan not stated
$194.29K 5,625 at 34.54
3.9%
9 Oct 2019
Chung Christine SVP, China Operations
Sold, plan not stated
$205.76K 5,625 at 36.58
3.9%
8 Oct 2019
Chung Christine SVP, China Operations
Sold, plan not stated 2×
$206.91K 5,625 at 36.78
3.9%
20 Sep 2019
Chung Christine SVP, China Operations
Sold, plan not stated
$224.27K 5,625 at 39.87
3.9%
19 Sep 2019
Chung Christine SVP, China Operations
Sold, plan not stated 2×
$227.55K 5,625 at 40.45
3.9%
16 Sep 2019
Yu K Peony Chief Medical Officer
Sold, plan not stated
$139.91K 3,419 at 40.92
1.9%
23 Aug 2019
Chung Christine SVP, China Operations
Sold, plan not stated 3×
$239.10K 5,625 at 42.51
3.6%
22 Aug 2019
Chung Christine SVP, China Operations
Sold, plan not stated 2×
$246.58K 5,625 at 43.84
3.6%
11 Jul 2019
Chung Christine SVP, China Operations
Sold, plan not stated 2×
$253.92K 5,625 at 45.14
3.6%
10 Jul 2019
Chung Christine SVP, China Operations
Sold, plan not stated 2×
$251.95K 5,625 at 44.79
3.6%
28 Jun 2019
Kouchakji Elias SVP, Clinical Dev, Drug Safety
Sold, plan not stated
$129.29K 2,873 at 45.00
2.6%
19 Jun 2019
Chung Christine SVP, China Operations
Sold, plan not stated
$247.61K 5,625 at 44.02
3.6%
18 Jun 2019
Chung Christine SVP, China Operations
Sold, plan not stated
$247.95K 5,625 at 44.08
3.6%
14 Jun 2019
Yu K Peony Chief Medical Officer
Sold, plan not stated
$140.08K 3,420 at 40.96
1.8%
Showing 1–50 of 75. Page 1 of 2 Older →